Semaglutide in Patients with MASLD/MASH, Obesity, and Type 2 Diabetes Mellitus: A Real-World Cohort Study, will be presented at this years American College of Gastroenterology meeting
If a compounded product is significantly cheaper but delivers inconsistent potency, the savings evaporate alongside the results
The researchers found semaglutide increases DVT by 226% in the trial patients
Product Specifications Purity : 99% (HPLC verified) Form : Lyophilized powder in a 5mL sterile vial Unit Size : 60mg per vial Storage : Store at -20C or below, protected from light Usage : For in vitro laboratory research only
The SURMOUNT-5 trial specifically excluded participants with type 2 diabetes, demonstrating its effectiveness independent of diabetes
While the authors did not mention concerns that this drop would be so drastic that it would cause low blood pressure, that is possible